ZIFLUC

This brand name is authorized in Nigeria.

Active ingredients

The drug ZIFLUC contains one active pharmaceutical ingredient (API):

1	Fluconazole UNII 8VZV102JFY - FLUCONAZOLE
	Fluconazole is a triazole antifungal agent. Its primary mode of action is the inhibition of fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis.
	Read more about Fluconazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-4535	Capsule	Zifluc Capsules++ CAP 50 mg 1 x 10's (in blister)	Capsule 6/14/2024 8:06:57 ZIFLUC CAPSULES FLUCONAZOLE A4-4535 CAPSULE ORAL FLUCONAZOLE FLUCONAZOLE 50MG X 10 POM SKG-PHARMA LIMITED 7/9 SAPARA STREET, OFF OBA AKRAN AVENUE, IKEJA LAGOS SKG-PHARMA LIMITED 7/9 SAPARA STREET, OFF OBA AKRAN AVENUE, IKEJA LAGOS NIGERIA 24/11/2022 23/11/2027 No J02AC01	24/11/2022

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J02AC01	Fluconazole	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AC Triazole and tetrazole derivatives
Discover more medicines within J02AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-4535